Toward tissue engineering of the knee meniscus

膝关节半月板组织工程

基本信息

项目摘要

DESCRIPTION (provided by applicant): This renewal proposal aims to tissue engineer an anisotropic meniscus construct that also captures the regional variations present in the native tissue. Subsequently, the construct will be implanted in a leporine model, using both allogenic and xenogenic cell sources, to achieve both meniscus repair and replacement. It is hypothesized that: 1) regionally variant, anisotropic, meniscus-shaped constructs can be engineered by optimizing cell culture and scaffoldless culture conditions; 2) the synergistic and strategic temporal application of certain anabolic and catabolic stimuli will enhance the functional properties of the maturing meniscus construct; and 3) both allogenic and xenogenic constructs can be successfully implanted in a leporine model. These hypotheses will be tested via the following three specific aims: 1) to create an anisotropic meniscus construct with regional variations mimicking native tissue, 2) to enhance functional and organizational properties of constructs via synergistic, temporally coordinated exogenous stimulation, and 3) to develop tissue-construct surgical fixation techniques and implant allogenic and xenogenic constructs in the rabbit. In the previous grant, the native meniscus was found to be highly anisotropic and regionally variant both morphologically and biomechanically, motivating our current tissue engineering approach to mimic these characteristics. Aim 1 will thus use co-cultures, meniscus-specific molds, and novel seeding techniques to accomplish this goal. Also identified in the previous grant were stimuli that had positive effects on a scaffold- based approach, but in parallel studies, it was clearly demonstrated that a scaffoldless approach, driven by the differential adhesion hypothesis, was superior. Aim 2 of this proposal will use such a scaffoldless approach, in conjunction with hydrostatic pressure, tension-compression, well confinement time, TGF-1, hypoxia, and chondroitinase-ABC to create tissue engineered constructs. Furthermore, the previous grant underscored the scarcity of meniscus cells that could be used in an in vivo study. Thus, in this proposal, to avoid the use of primary cells, we will investigate the use of passaged allogenic cells and, for the first time, a xenogenic cell source in the in vivo repair and replacement of the meniscus (Aim 3). By examining both allogenic and xenogenic cell sources, this proposal seeks to obviate the issue of tissue scarcity (either autologous or allogenic meniscus and cartilage) and aims to provide a solution to the complex problem of meniscus regeneration. PUBLIC HEALTH RELEVANCE: Establishing the means to tissue engineer and implant meniscus tissue would bode well for over one million Americans that undergo meniscal procedures annually. However, the highly anisotropic mechanical properties and morphological regional variance observed in native tissue render recapitulating these structure/function relationship a complex problem. The current tissue engineering approach seeks to mimic these characteristics to produce anisotropic, inhomogeneous allogenic and/or xenogenic constructs that can restore the functional properties of the knee meniscus. Successful completion of this proposal will establish a framework for future scaffoldless meniscus regeneration attempts using alternate cell sources for the repair and replacement of meniscus tissue.
描述(申请人提供):该更新方案旨在组织工程一种各向异性半月板结构,该结构还能捕捉天然组织中存在的区域变化。随后,该构建物将被植入Leporine模型,使用同种和异种细胞来源,以实现半月板修复和替换。假设:1)通过优化细胞培养和无支架培养条件,可以设计出区域变异的、各向异性的半月板形状的结构;2)某些合成代谢和分解代谢刺激的协同和战略性的时间应用将增强成熟的半月板结构的功能特性;3)异体和异种结构都可以成功地植入Leporine模型。这些假说将通过以下三个具体目标得到验证:1)创建模仿天然组织的各向异性半月板结构,2)通过协同的、时间上协调的外源刺激来增强结构的功能和组织性能,3)开发组织结构外科固定技术,并在兔体内植入同种和异种结构。在之前的资助中,发现自然半月板在形态和生物力学上都是高度各向异性和区域变异的,这促使我们目前的组织工程学方法来模拟这些特征。因此,目标1将使用共培养、半月板特定的霉菌和新颖的播种技术来实现这一目标。在上一笔赠款中也发现了对支架方法有积极影响的刺激,但在平行研究中,清楚地证明了由差异黏附假说驱动的无支架方法更优越。该提案的目标2将使用这种无支架方法,结合静水压力、拉伸-压缩、良好限制时间、转化生长因子-1、低氧和软骨素酶-ABC来创建组织工程化构建物。此外,之前的拨款强调了可用于活体研究的半月板细胞的稀缺性。因此,在这项提案中,为了避免使用原代细胞,我们将研究传代的同种异体细胞的使用,并首次研究异种细胞来源在半月板体内修复和替换中的应用(目标3)。通过对同种和异种细胞来源的研究,这项建议试图避免组织稀缺的问题(无论是自体或同种异体半月板和软骨),并旨在为半月板再生这一复杂的问题提供解决方案。与公共卫生相关:建立组织工程和植入半月板组织的方法对每年接受半月板手术的100多万美国人来说是个好兆头。然而,在天然组织中观察到的高度各向异性的力学特性和形态区域差异使得概括这些结构/功能关系成为一个复杂的问题。目前的组织工程学方法试图模仿这些特征来产生各向异性、不均匀的同种和/或异种结构,以恢复膝关节半月板的功能特性。这项提议的成功完成将为未来的无支架半月板再生尝试建立一个框架,使用替代细胞来源修复和替换半月板组织。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kyriacos A Athanasiou其他文献

Characterization of the temporomandibular joint disc complex in the Yucatan minipig.
尤卡坦小型猪颞下颌关节盘复合体的特征。
  • DOI:
    10.1089/ten.tea.2023.0011
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    R. Donahue;Eston G Kallins;Jerry C. Hu;Kyriacos A Athanasiou
  • 通讯作者:
    Kyriacos A Athanasiou
Mechanical Evaluation of Commercially Available Fibrin Sealants for Cartilage Repair.
用于软骨修复的市售纤维蛋白密封剂的机械评估。
  • DOI:
    10.1177/19476035231163273
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    2.8
  • 作者:
    Arya Amirhekmat;W. E. Brown;E. Y. Salinas;Jerry C. Hu;Kyriacos A Athanasiou;Dean Wang
  • 通讯作者:
    Dean Wang
Adult dermal stem cells for scaffold-free cartilage tissue engineering - exploration of strategies.
用于无支架软骨组织工程的成体真皮干细胞——策略探索。
  • DOI:
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    0
  • 作者:
    N. Vapniarsky;H. Kwon;N. Paschos;A. Haudenschild;W. E. Brown;Gayson DuRaine;Jerry C. Hu;Kyriacos A Athanasiou
  • 通讯作者:
    Kyriacos A Athanasiou

Kyriacos A Athanasiou的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kyriacos A Athanasiou', 18)}}的其他基金

Liquid cartilage for arthroscopy
关节镜用液体软骨
  • 批准号:
    10649312
  • 财政年份:
    2023
  • 资助金额:
    $ 37.79万
  • 项目类别:
Laser Scanning Vibrometer
激光扫描测振仪
  • 批准号:
    10415806
  • 财政年份:
    2022
  • 资助金额:
    $ 37.79万
  • 项目类别:
Toward tissue engineering of facet cartilage
面向小面软骨的组织工程
  • 批准号:
    10398793
  • 财政年份:
    2021
  • 资助金额:
    $ 37.79万
  • 项目类别:
Toward tissue engineering of facet cartilage
面向小面软骨的组织工程
  • 批准号:
    10571696
  • 财政年份:
    2021
  • 资助金额:
    $ 37.79万
  • 项目类别:
TMJ Disc Regeneration
颞下颌关节盘再生
  • 批准号:
    10238212
  • 财政年份:
    2020
  • 资助金额:
    $ 37.79万
  • 项目类别:
TMJ Disc Regeneration
颞下颌关节盘再生
  • 批准号:
    9930175
  • 财政年份:
    2019
  • 资助金额:
    $ 37.79万
  • 项目类别:
Engineering biomimetic knee menisci with zonal and anisotropic variations
具有分区和各向异性变化的仿生膝关节半月板工程
  • 批准号:
    10199936
  • 财政年份:
    2017
  • 资助金额:
    $ 37.79万
  • 项目类别:
Engineering biomimetic knee menisci with zonal and anisotropic variations
具有分区和各向异性变化的仿生膝关节半月板工程
  • 批准号:
    10425800
  • 财政年份:
    2017
  • 资助金额:
    $ 37.79万
  • 项目类别:
Engineering biomimetic knee menisci with zonal and anisotropic variations
具有分区和各向异性变化的仿生膝关节半月板工程
  • 批准号:
    9755363
  • 财政年份:
    2017
  • 资助金额:
    $ 37.79万
  • 项目类别:
Self-assembling process in tissue engineering of articular cartilage
关节软骨组织工程中的自组装过程
  • 批准号:
    9755352
  • 财政年份:
    2017
  • 资助金额:
    $ 37.79万
  • 项目类别:

相似海外基金

HLA-homozygous iPSC-cardiomyocytE Aggregate manufacturing technoLogies for allogenic cell therapy to the heart (HEAL)
HLA-纯合 iPSC-心肌细胞 用于心脏同种异体细胞治疗 (HEAL) 的聚集体制造技术
  • 批准号:
    10039902
  • 财政年份:
    2022
  • 资助金额:
    $ 37.79万
  • 项目类别:
    EU-Funded
Evaluation of the efficacy of LAT1 inhibitor to tumor stroma and immunity in an allogenic mouse model of colon cancer having abundant stroma.
在具有丰富基质的同种异体结肠癌小鼠模型中评估 LAT1 抑制剂对肿瘤基质和免疫的功效。
  • 批准号:
    21K15925
  • 财政年份:
    2021
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mechanism of kidney injury associated with graft-versus-host disease after allogenic stem cell transplantation
同种异体干细胞移植后移植物抗宿主病相关肾损伤的机制
  • 批准号:
    21K08410
  • 财政年份:
    2021
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clarification of the origin and maintenance mechanisms of junctional epithelium and identification of its stem cells using allogenic tooth germ transplantation
阐明交界上皮的起源和维持机制并利用同种异体牙胚移植鉴定其干细胞
  • 批准号:
    20K21672
  • 财政年份:
    2020
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
The study about the allogenic MSCs transplantation to the cardiac disease models.
同种异体间充质干细胞移植至心脏病模型的研究。
  • 批准号:
    18K16395
  • 财政年份:
    2018
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Artificial nerves containing allogenic basal lamellae scaffold and bone marrow derived stem cells
含有同种异体基底板层支架和骨髓干细胞的人工神经
  • 批准号:
    17K10951
  • 财政年份:
    2017
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Role of HSP90-alpha in preserving immunoprivilege of allogenic mesenchymal stem cells in the ischemic heart
HSP90-α 在保护缺血心脏同种异体间充质干细胞免疫特权中的作用
  • 批准号:
    370541
  • 财政年份:
    2017
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Operating Grants
Attempt to Prefabricate Vascularized Allogenic Bone in Recipient -Use of Cultured Bone Marrow Cells-
尝试在受者体内预制血管化的同种异体骨 - 使用培养的骨髓细胞 -
  • 批准号:
    16K10863
  • 财政年份:
    2016
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Allogenic micobiota-reconstitution (AMR) for the treatment of patients with diarhea-predominant irritable bowel syndrome (IBS-D) - the AMIRA trial
同种异体微生物群重建 (AMR) 用于治疗腹泻型肠易激综合征 (IBS-D) 患者 - AMIRA 试验
  • 批准号:
    276706135
  • 财政年份:
    2015
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Clinical Trials
Induction of thyme epithelial cells from iPS cells and application to allogenic transplantation
iPS细胞诱导百里香上皮细胞及其在同种异体移植中的应用
  • 批准号:
    15H04915
  • 财政年份:
    2015
  • 资助金额:
    $ 37.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了